Last 12 months
Inside the activity.
6 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 4 | 0 |
| Dec 2025 | 2 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 25, 2020 Filed Jun 8, 2020 21:58 UTC |
Branitzky OronDirector
|
GrantOption to purchase Common Stock (right to buy) · Derivative | 1,000 | Not disclosed Strike: $1.04 | Not disclosed |
DisclosureSEC source: 0001213900-20-014432 · ownership.xml · derivative · entry 6 Braniztky Oron · CIK 0001714993 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Underlying: Common Stock, $.001 par value per share · 1,000 shares Expires 2025-05-29 F4 · price: Effective May 25, 2020, the Board of Directors of the Company approved a unilateral option repricing and term extension, which resulted in the reduction of the exercise price to $1.04 per share, which is the closing price of the Company's common stock on May 22, 2020, and an expiration date of May 29, 2025. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, of which all options have vested. Read SEC document |
| May 25, 2020 Filed Jun 8, 2020 21:58 UTC |
Branitzky OronDirector
|
Disposition to issuerOption to purchase Common Stock (right to buy) · Derivative | 1,000 | Not disclosed Strike: $11.40 | Not disclosed |
DisclosureSEC source: 0001213900-20-014432 · ownership.xml · derivative · entry 5 Braniztky Oron · CIK 0001714993 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $.001 par value per share · 1,000 shares Expires 2024-05-29 F4 · price: Effective May 25, 2020, the Board of Directors of the Company approved a unilateral option repricing and term extension, which resulted in the reduction of the exercise price to $1.04 per share, which is the closing price of the Company's common stock on May 22, 2020, and an expiration date of May 29, 2025. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, of which all options have vested. Read SEC document |
| May 25, 2020 Filed Jun 8, 2020 21:58 UTC |
Branitzky OronDirector
|
GrantOption to purchase Common Stock (right to buy) · Derivative | 667 | Not disclosed Strike: $1.04 | Not disclosed |
DisclosureSEC source: 0001213900-20-014432 · ownership.xml · derivative · entry 4 Braniztky Oron · CIK 0001714993 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 667 Underlying: Common Stock, $.001 par value per share · 667 shares Expires 2024-09-06 F3 · price: Effective May 25, 2020, the Board of Directors of the Company approved a unilateral option repricing and term extension, which resulted in the reduction of the exercise price to $1.04 per share, which is the closing price of the Company's common stock on May 22, 2020, and an expiration date of September 6, 2024. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, of which all options have vested. Read SEC document |
| May 25, 2020 Filed Jun 8, 2020 21:58 UTC |
Branitzky OronDirector
|
Disposition to issuerOption to purchase Common Stock (right to buy) · Derivative | 667 | Not disclosed Strike: $13.65 | Not disclosed |
DisclosureSEC source: 0001213900-20-014432 · ownership.xml · derivative · entry 3 Braniztky Oron · CIK 0001714993 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $.001 par value per share · 667 shares Expires 2023-09-06 F3 · price: Effective May 25, 2020, the Board of Directors of the Company approved a unilateral option repricing and term extension, which resulted in the reduction of the exercise price to $1.04 per share, which is the closing price of the Company's common stock on May 22, 2020, and an expiration date of September 6, 2024. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, of which all options have vested. Read SEC document |
| May 25, 2020 Filed Jun 8, 2020 21:58 UTC |
Branitzky OronDirector
|
GrantOption to purchase Common Stock (right to buy) · Derivative | 667 | Not disclosed Strike: $1.04 | Not disclosed |
DisclosureSEC source: 0001213900-20-014432 · ownership.xml · derivative · entry 2 Braniztky Oron · CIK 0001714993 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 667 Underlying: Common Stock, $.001 par value per share · 667 shares Expires 2023-07-24 F2 · price: Effective May 25, 2020, the Board of Directors of the Company approved a unilateral option repricing and term extension, which resulted in the reduction of the exercise price to $1.04 per share, which is the closing price of the Company's common stock on May 22, 2020, and an expiration date of July 24, 2023. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, of which all options have vested. Read SEC document |
| May 25, 2020 Filed Jun 8, 2020 21:58 UTC |
Branitzky OronDirector
|
Disposition to issuerOption to purchase Common Stock (right to buy) · Derivative | 667 | Not disclosed Strike: $18.15 | Not disclosed |
DisclosureSEC source: 0001213900-20-014432 · ownership.xml · derivative · entry 1 Braniztky Oron · CIK 0001714993 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $.001 par value per share · 667 shares Expires 2022-07-24 F2 · price: Effective May 25, 2020, the Board of Directors of the Company approved a unilateral option repricing and term extension, which resulted in the reduction of the exercise price to $1.04 per share, which is the closing price of the Company's common stock on May 22, 2020, and an expiration date of July 24, 2023. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, of which all options have vested. Read SEC document |
| May 25, 2020 Filed Jun 8, 2020 21:53 UTC |
Kaufman ArikDirector
|
GrantOption to purchase Common Stock (right to buy) · Derivative | 1,000 | Not disclosed Strike: $1.04 | Not disclosed |
DisclosureSEC source: 0001213900-20-014424 · ownership.xml · derivative · entry 6 Kaufman Arik · CIK 0001713725 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Underlying: Common Stock, $.001 par value per share · 1,000 shares Expires 2025-05-29 F4 · price: Effective May 25, 2020, the Board of Directors of the Company approved a unilateral option repricing and term extension, which resulted in the reduction of the exercise price to $1.04 per share, which is the closing price of the Company's common stock on May 22, 2020, and an expiration date of May 29, 2025. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, of which all options have vested. Read SEC document |
| May 25, 2020 Filed Jun 8, 2020 21:53 UTC |
Kaufman ArikDirector
|
Disposition to issuerOption to purchase Common Stock (right to buy) · Derivative | 1,000 | Not disclosed Strike: $11.40 | Not disclosed |
DisclosureSEC source: 0001213900-20-014424 · ownership.xml · derivative · entry 5 Kaufman Arik · CIK 0001713725 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $.001 par value per share · 1,000 shares Expires 2024-05-29 F4 · price: Effective May 25, 2020, the Board of Directors of the Company approved a unilateral option repricing and term extension, which resulted in the reduction of the exercise price to $1.04 per share, which is the closing price of the Company's common stock on May 22, 2020, and an expiration date of May 29, 2025. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, of which all options have vested. Read SEC document |
| May 25, 2020 Filed Jun 8, 2020 21:53 UTC |
Kaufman ArikDirector
|
GrantOption to purchase Common Stock (right to buy) · Derivative | 667 | Not disclosed Strike: $1.04 | Not disclosed |
DisclosureSEC source: 0001213900-20-014424 · ownership.xml · derivative · entry 4 Kaufman Arik · CIK 0001713725 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 667 Underlying: Common Stock, $.001 par value per share · 667 shares Expires 2024-09-06 F3 · price: Effective May 25, 2020, the Board of Directors of the Company approved a unilateral option repricing and term extension, which resulted in the reduction of the exercise price to $1.04 per share, which is the closing price of the Company's common stock on May 22, 2020, and an expiration date of September 6, 2024. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, of which all options have vested. Read SEC document |
| May 25, 2020 Filed Jun 8, 2020 21:53 UTC |
Kaufman ArikDirector
|
Disposition to issuerOption to purchase Common Stock (right to buy) · Derivative | 667 | Not disclosed Strike: $13.65 | Not disclosed |
DisclosureSEC source: 0001213900-20-014424 · ownership.xml · derivative · entry 3 Kaufman Arik · CIK 0001713725 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $.001 par value per share · 667 shares Expires 2023-09-06 F3 · price: Effective May 25, 2020, the Board of Directors of the Company approved a unilateral option repricing and term extension, which resulted in the reduction of the exercise price to $1.04 per share, which is the closing price of the Company's common stock on May 22, 2020, and an expiration date of September 6, 2024. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, of which all options have vested. Read SEC document |
| May 25, 2020 Filed Jun 8, 2020 21:53 UTC |
Kaufman ArikDirector
|
GrantOption to purchase Common Stock (right to buy) · Derivative | 667 | Not disclosed Strike: $1.04 | Not disclosed |
DisclosureSEC source: 0001213900-20-014424 · ownership.xml · derivative · entry 2 Kaufman Arik · CIK 0001713725 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 667 Underlying: Common Stock, $.001 par value per share · 667 shares Expires 2023-07-24 F2 · price: Effective May 25, 2020, the Board of Directors of the Company approved a unilateral option repricing and term extension, which resulted in the reduction of the exercise price to $1.04 per share, which is the closing price of the Company's common stock on May 22, 2020, and an expiration date of July 24, 2023. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, of which all options have vested. Read SEC document |
| May 25, 2020 Filed Jun 8, 2020 21:53 UTC |
Kaufman ArikDirector
|
Disposition to issuerOption to purchase Common Stock (right to buy) · Derivative | 667 | Not disclosed Strike: $18.15 | Not disclosed |
DisclosureSEC source: 0001213900-20-014424 · ownership.xml · derivative · entry 1 Kaufman Arik · CIK 0001713725 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $.001 par value per share · 667 shares Expires 2022-07-24 F2 · price: Effective May 25, 2020, the Board of Directors of the Company approved a unilateral option repricing and term extension, which resulted in the reduction of the exercise price to $1.04 per share, which is the closing price of the Company's common stock on May 22, 2020, and an expiration date of July 24, 2023. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, of which all options have vested. Read SEC document |
| May 30, 2019 Filed Jun 3, 2019 21:32 UTC |
Pardo BillyChief Product Officer and COO
|
GrantOption to purchase Common Stock (right to buy) · Derivative | 500,000 | $0.00 Strike: $0.76 | $0.00 |
DisclosureSEC source: 0001213900-19-009988 · ownership.xml · derivative · entry 4 Pardo Billy · CIK 0001686858 · Chief Product Officer and COO 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 500,000 Underlying: Common Stock, $.001 par value per share · 500,000 shares Expires 2024-05-30 F2 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan. The option vested and became exercisable as to one-third of the total shares on January 24, 2019 and vests and becomes exercisable as to one third of the total shares on January 24, 2020 and as to the remaining shares on January 24, 2021. F3 · ownership.nature: Options acquired by Spouse (Chief Executive Officer and Director Ronen Luzon). Read SEC document |
| May 30, 2019 Filed Jun 3, 2019 21:32 UTC |
Pardo BillyChief Product Officer and COO
|
GrantOption to purchase Common Stock (right to buy) · Derivative | 100,000 | $0.00 Strike: $0.76 | $0.00 |
DisclosureSEC source: 0001213900-19-009988 · ownership.xml · derivative · entry 3 Pardo Billy · CIK 0001686858 · Chief Product Officer and COO 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 100,000 Underlying: Common Stock, $.001 par value per share · 100,000 shares Expires 2024-05-30 F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan. All options vested immediately upon grant. F3 · ownership.nature: Options acquired by Spouse (Chief Executive Officer and Director Ronen Luzon). Read SEC document |
| May 30, 2019 Filed Jun 3, 2019 21:32 UTC |
Pardo BillyChief Product Officer and COO
|
GrantOption to purchase Common Stock (right to buy) · Derivative | 255,000 | $0.00 Strike: $0.76 | $0.00 |
DisclosureSEC source: 0001213900-19-009988 · ownership.xml · derivative · entry 2 Pardo Billy · CIK 0001686858 · Chief Product Officer and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,000 Underlying: Common Stock, $.001 par value per share · 255,000 shares Expires 2024-05-30 F2 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan. The option vested and became exercisable as to one-third of the total shares on January 24, 2019 and vests and becomes exercisable as to one third of the total shares on January 24, 2020 and as to the remaining shares on January 24, 2021. Read SEC document |
| May 30, 2019 Filed Jun 3, 2019 21:32 UTC |
Pardo BillyChief Product Officer and COO
|
GrantOption to purchase Common Stock (right to buy) · Derivative | 80,000 | $0.00 Strike: $0.76 | $0.00 |
DisclosureSEC source: 0001213900-19-009988 · ownership.xml · derivative · entry 1 Pardo Billy · CIK 0001686858 · Chief Product Officer and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock, $.001 par value per share · 80,000 shares Expires 2024-05-30 F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan. All options vested immediately upon grant. Read SEC document |
| May 30, 2019 Filed Jun 3, 2019 21:31 UTC |
Elmaliah OrenDirector
|
GrantOption to purchase Common Stock (right to buy) · Derivative | 15,000 | $0.00 Strike: $0.76 | $0.00 |
DisclosureSEC source: 0001213900-19-009984 · ownership.xml · derivative · entry 1 Elmaliah Oren · CIK 0001713701 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock, $.001 par value per share · 15,000 shares Expires 2024-05-30 F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, of which no options have vested to date. All 15,000 options shall vest on December 31, 2019. Read SEC document |
| May 30, 2019 Filed Jun 3, 2019 21:31 UTC |
Kles OrChief Financial Officer
|
GrantOption to purchase Common Stock (right to buy) · Derivative | 150,000 | $0.00 Strike: $0.76 | $0.00 |
DisclosureSEC source: 0001213900-19-009986 · ownership.xml · derivative · entry 2 Kles Or · CIK 0001686316 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock, $.001 par value per share · 150,000 shares Expires 2024-05-30 F2 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, of which no options have vested to date. The option vests and becomes exercisable as to one-third of the total shares on each of May 1, 2020, May 1, 2021 and May 1, 2022. Read SEC document |
| May 30, 2019 Filed Jun 3, 2019 21:31 UTC |
Kles OrChief Financial Officer
|
GrantOption to purchase Common Stock (right to buy) · Derivative | 60,000 | $0.00 Strike: $0.76 | $0.00 |
DisclosureSEC source: 0001213900-19-009986 · ownership.xml · derivative · entry 1 Kles Or · CIK 0001686316 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock, $.001 par value per share · 60,000 shares Expires 2024-05-30 F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan. All options vested immediately upon grant. Read SEC document |
| May 30, 2019 Filed Jun 3, 2019 21:32 UTC |
Luzon RonenDirector · Chief Executive Officer
|
GrantOption to purchase Common Stock (right to buy) · Derivative | 255,000 | $0.00 Strike: $0.76 | $0.00 |
DisclosureSEC source: 0001213900-19-009987 · ownership.xml · derivative · entry 4 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 255,000 Underlying: Common Stock, $.001 par value per share · 255,000 shares Expires 2024-05-30 F2 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan. The option vested and became exercisable as to one-third of the total shares on January 24, 2019 and vests and becomes exercisable as to one third of the total shares on January 24, 2020 and as to the remaining shares on January 24, 2021. F3 · ownership.nature: Options acquired by Spouse (Chief Product Officer and Chief Operating Officer Billy Pardo). Read SEC document |
| May 30, 2019 Filed Jun 3, 2019 21:32 UTC |
Luzon RonenDirector · Chief Executive Officer
|
GrantOption to purchase Common Stock (right to buy) · Derivative | 80,000 | $0.00 Strike: $0.76 | $0.00 |
DisclosureSEC source: 0001213900-19-009987 · ownership.xml · derivative · entry 3 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 80,000 Underlying: Common Stock, $.001 par value per share · 80,000 shares Expires 2024-05-30 F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan. All options vested immediately upon grant. F3 · ownership.nature: Options acquired by Spouse (Chief Product Officer and Chief Operating Officer Billy Pardo). Read SEC document |
| May 30, 2019 Filed Jun 3, 2019 21:32 UTC |
Luzon RonenDirector · Chief Executive Officer
|
GrantOption to purchase Common Stock (right to buy) · Derivative | 500,000 | $0.00 Strike: $0.76 | $0.00 |
DisclosureSEC source: 0001213900-19-009987 · ownership.xml · derivative · entry 2 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock, $.001 par value per share · 500,000 shares Expires 2024-05-30 F2 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan. The option vested and became exercisable as to one-third of the total shares on January 24, 2019 and vests and becomes exercisable as to one third of the total shares on January 24, 2020 and as to the remaining shares on January 24, 2021. Read SEC document |
| May 30, 2019 Filed Jun 3, 2019 21:32 UTC |
Luzon RonenDirector · Chief Executive Officer
|
GrantOption to purchase Common Stock (right to buy) · Derivative | 100,000 | $0.00 Strike: $0.76 | $0.00 |
DisclosureSEC source: 0001213900-19-009987 · ownership.xml · derivative · entry 1 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock, $.001 par value per share · 100,000 shares Expires 2024-05-30 F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan. All options vested immediately upon grant. Read SEC document |
| May 30, 2019 Filed Jun 4, 2019 01:31 UTC |
Kaufman ArikDirector
|
GrantOption to purchase Common Stock (right to buy) · Derivative | 15,000 | $0.00 Strike: $0.76 | $0.00 |
DisclosureSEC source: 0001213900-19-009985 · ownership.xml · derivative · entry 1 Kaufman Arik · CIK 0001713725 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock, $.001 par value per share · 15,000 shares Expires 2024-05-30 F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, of which no options have vested to date. All 15,000 options shall vest on December 31, 2019. Read SEC document |
| May 30, 2019 Filed Jun 4, 2019 01:30 UTC |
Branitzky OronDirector
|
GrantOption to purchase Common Stock (right to buy) · Derivative | 15,000 | $0.00 Strike: $0.76 | $0.00 |
DisclosureSEC source: 0001213900-19-009983 · ownership.xml · derivative · entry 1 Braniztky Oron · CIK 0001714993 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock, $.001 par value per share · 15,000 shares Expires 2024-05-30 F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, of which no options have vested to date. All 15,000 options shall vest on December 31, 2019. Read SEC document |
| May 30, 2019 Filed Jun 27, 2019 21:21 UTC |
Turchinsky IliaChief Technology Officer
|
GrantOption to purchase Common Stock (right to buy) · Derivative | 15,050 | $0.00 Strike: $0.76 | $0.00 |
DisclosureSEC source: 0001213900-19-011677 · ownership.xml · derivative · entry 1 Turchinsky Ilia · CIK 0001774527 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,050 Underlying: Common Stock, $.001 par value per share · 15,050 shares Expires 2024-05-30 F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan. All options vested immediately upon grant. Read SEC document |
| September 06, 2018 Filed Jan 30, 2019 16:19 UTC |
Elmaliah OrenDirector
|
GrantOption to purchase Common Stock (right to buy) · Derivative | 10,000 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001213900-19-001443 · ownership.xml · derivative · entry 1 Elmaliah Oren · CIK 0001713701 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock, $.001 par value per share · 10,000 shares Expires 2023-09-06 F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, of which no options have vested to date. All 10,000 options shall vest on September 6, 2019. Read SEC document |
| September 06, 2018 Filed Jan 30, 2019 21:21 UTC |
Kaufman ArikDirector
|
GrantOption to purchase Common Stock (right to buy) · Derivative | 10,000 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001213900-19-001447 · ownership.xml · derivative · entry 1 Kaufman Arik · CIK 0001713725 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock, $.001 par value per share · 10,000 shares Expires 2023-09-06 F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, of which no options have vested to date. All 10,000 options shall vest on September 6, 2019. Read SEC document |
| September 06, 2018 Filed Jan 30, 2019 21:18 UTC |
Branitzky OronDirector
|
GrantOption to purchase Common Stock (right to buy) · Derivative | 10,000 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001213900-19-001441 · ownership.xml · derivative · entry 1 Braniztky Oron · CIK 0001714993 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock, $.001 par value per share · 10,000 shares Expires 2023-09-06 F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, of which no options have vested to date. All 10,000 options shall vest on September 6, 2019. Read SEC document |
| February 02, 2018 Filed Feb 7, 2018 11:35 UTC |
LEVY ISRAEL5% owner
|
Salemysz common stock | 981,050 | $0.65 | $637,682.50 |
DisclosureSEC source: 0001413439-18-000001 · primary_doc.xml · nonDerivative · entry 1 LEVY ISRAEL · CIK 0001413439 · 5% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 456,800 Read SEC document |
| July 24, 2017 Filed Jul 26, 2017 16:52 UTC |
Shoshan OdedChief Technical Officer
|
GrantOption to purchase Common Stock (right to buy) · Derivative | 45,000 | $0.00 Strike: $1.21 | $0.00 |
DisclosureSEC source: 0001213900-17-007936 · f4072417shoshan_mysize.xml · derivative · entry 1 Shoshan Oded · CIK 0001691292 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock, $.001 par value per share · 45,000 shares Expires 2022-07-24 F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, of which no options have vested to date. All 45,000 options shall vest on January 24, 2018. Read SEC document |
| July 24, 2017 Filed Jul 26, 2017 16:49 UTC |
Pardo BillyChief Product Officer
|
GrantOption to purchase Common Stock (right to buy) · Derivative | 150,000 | $0.00 Strike: $1.21 | $0.00 |
DisclosureSEC source: 0001213900-17-007932 · f4072417luzonbilly_mysize.xml · derivative · entry 2 Luzon Billy Balla · CIK 0001686858 · Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 150,000 Underlying: Common Stock, $.001 par value per share · 150,000 shares Expires 2022-07-24 F2 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, none of which options have vested. All of such options shall vest on January 24, 2018. F3 · ownership.direct: Options acquired by Spouse (Chief Executive Officer and Director Ronen Luzon). F3 · ownership.nature: Options acquired by Spouse (Chief Executive Officer and Director Ronen Luzon). Read SEC document |
| July 24, 2017 Filed Jul 26, 2017 16:49 UTC |
Pardo BillyChief Product Officer
|
GrantOption to purchase Common Stock (right to buy) · Derivative | 150,000 | $0.00 Strike: $1.21 | $0.00 |
DisclosureSEC source: 0001213900-17-007932 · f4072417luzonbilly_mysize.xml · derivative · entry 1 Luzon Billy Balla · CIK 0001686858 · Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock, $.001 par value per share · 150,000 shares Expires 2022-07-24 F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, none of which options have vested. All of such options shall vest on January 24, 2018. Read SEC document |
| July 24, 2017 Filed Jul 26, 2017 16:48 UTC |
Kles OrChief Financial Officer
|
GrantOption to purchase Common Stock (right to buy) · Derivative | 85,000 | $0.00 Strike: $1.21 | $0.00 |
DisclosureSEC source: 0001213900-17-007931 · f4072417kles_mysize.xml · derivative · entry 1 Kles Or · CIK 0001686316 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,000 Underlying: Common Stock, $.001 par value per share · 85,000 shares Expires 2022-07-24 F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, which shall vest as to 28,333 immediately, as to 28,333 on May 1, 2018, and as to 28,334 on May 1, 2019. Read SEC document |
| July 24, 2017 Filed Jul 26, 2017 16:54 UTC |
Walles EliyahuDirector
|
GrantOption to purchase Common Stock (right to buy) · Derivative | 300,000 | $0.00 Strike: $1.21 | $0.00 |
DisclosureSEC source: 0001213900-17-007938 · f4072417walles_mysize.xml · derivative · entry 1 Walles Eliyahu · CIK 0001686317 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock, $.001 par value per share · 300,000 shares Expires 2022-07-24 F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, of which no options have vested to date. All 300,000 options shall vest on January 24, 2018. Read SEC document |
| July 24, 2017 Filed Jul 26, 2017 16:51 UTC |
Luzon RonenDirector · Chief Executive Officer
|
GrantOption to purchase Common Stock (right to buy) · Derivative | 150,000 | $0.00 Strike: $1.21 | $0.00 |
DisclosureSEC source: 0001213900-17-007934 · f4072417luzonronen_mysize.xml · derivative · entry 2 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 150,000 Underlying: Common Stock, $.001 par value per share · 150,000 shares Expires 2022-07-24 F2 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, none of which options have vested. All of such options shall vest on January 24, 2018. F3 · ownership.direct: Options acquired by Spouse (Chief Product Officer Billy Luzon). F3 · ownership.nature: Options acquired by Spouse (Chief Product Officer Billy Luzon). Read SEC document |
| July 24, 2017 Filed Jul 26, 2017 16:51 UTC |
Luzon RonenDirector · Chief Executive Officer
|
GrantOption to purchase Common Stock (right to buy) · Derivative | 150,000 | $0.00 Strike: $1.21 | $0.00 |
DisclosureSEC source: 0001213900-17-007934 · f4072417luzonronen_mysize.xml · derivative · entry 1 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock, $.001 par value per share · 150,000 shares Expires 2022-07-24 F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, none of which options have vested. All of such options shall vest on January 24, 2018. Read SEC document |
| July 24, 2017 Filed Aug 3, 2017 06:58 UTC |
Elmaliah OrenDirector
|
GrantOption to purchase Common Stock (right to buy) · Derivative | 10,000 | $0.00 Strike: $1.21 | $0.00 |
DisclosureSEC source: 0001213900-17-008170 · f4072417elmaliah_mysizeinc.xml · derivative · entry 1 Elmaliah Oren · CIK 0001713701 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock, $.001 par value per share · 10,000 shares Expires 2022-07-24 F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, of which no options have vested to date. All 10,000 options shall vest on July 24, 2018. Read SEC document |
| July 24, 2017 Filed Aug 3, 2017 11:00 UTC |
Kaufman ArikDirector
|
GrantOption to purchase Common Stock (right to buy) · Derivative | 10,000 | $0.00 Strike: $1.21 | $0.00 |
DisclosureSEC source: 0001213900-17-008172 · f4072417kaufman_mysizeinc.xml · derivative · entry 1 Kaufman Arik · CIK 0001713725 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock, $.001 par value per share · 10,000 shares Expires 2022-07-24 F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, of which no options have vested to date. All 10,000 options shall vest on July 24, 2018. Read SEC document |
| July 24, 2017 Filed Aug 17, 2017 19:16 UTC |
Branitzky OronDirector
|
GrantOption to purchase Common Stock (right to buy) · Derivative | 10,000 | $0.00 Strike: $1.21 | $0.00 |
DisclosureSEC source: 0001213900-17-008879 · f4072417branitzky_mysizeinc.xml · derivative · entry 1 Braniztky Oron · CIK 0001714993 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock, $.001 par value per share · 10,000 shares Expires 2022-07-24 F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, of which no options have vested to date. All 10,000 options shall vest on July 24, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.